Disir
Platinum Member
- Sep 30, 2011
- 28,003
- 9,608
- 910
MANCHESTER, NH – Dean Kamen on Friday announced the launch of BioFabUSA, a new biomedical manufacturing company focused on the research, development, and creation of artificial tissue growth.
Headed by Kamen of DEKA Research and Development Corp, BioFabUSA operates under the umbrella of the Advanced Regenerative Manufacturing Institute (ARMI), a non-profit organization whose mission, according to Kamen, is to “make practical the large-scale manufacturing of engineered tissues and organs, and to develop a trained and ready workforce necessary for that manufacturing.”
ARMI is a public-private partnership, funded by an $80 million grant from the Department of Defense and over $210 million raised by Kamen through investors. Kamen plans to incorporate a mix of academic institutions and private enterprises to assist in BioFabUSA’s mission.
Dean Kamen launches ARMI, aimed at tissue growth and engineering - Manchester Ink Link
Manchester will be turned into a health hub.
Headed by Kamen of DEKA Research and Development Corp, BioFabUSA operates under the umbrella of the Advanced Regenerative Manufacturing Institute (ARMI), a non-profit organization whose mission, according to Kamen, is to “make practical the large-scale manufacturing of engineered tissues and organs, and to develop a trained and ready workforce necessary for that manufacturing.”
ARMI is a public-private partnership, funded by an $80 million grant from the Department of Defense and over $210 million raised by Kamen through investors. Kamen plans to incorporate a mix of academic institutions and private enterprises to assist in BioFabUSA’s mission.
Dean Kamen launches ARMI, aimed at tissue growth and engineering - Manchester Ink Link
Manchester will be turned into a health hub.
